Related references
Note: Only part of the references are listed.Tailoring the properties of (catalytically)-active inclusion bodies
V. D. Jaeger et al.
MICROBIAL CELL FACTORIES (2019)
Facile preparation of metal organic frameworks-based hydrophobic anticancer drug delivery nanoplatform for targeted and enhanced cancer treatment
Kai Dong et al.
TALANTA (2019)
Targeting Antitumoral Proteins to Breast Cancer by Local Administration of Functional Inclusion Bodies
Mireia Pesarrodona et al.
ADVANCED SCIENCE (2019)
Metal-Organic Frameworks as Drug Delivery Platforms for Ocular Therapeutics
Jesus Gandara-Loe et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Development of Biocompatible Iron-Carboxylate Metal Organic Frameworks for pH-Responsive Drug Delivery Application
Vandana Gupta et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2019)
Bacterial inclusion bodies are industrially exploitable amyloids
Ario de Marco et al.
FEMS MICROBIOLOGY REVIEWS (2019)
Injectable nanocomposite cryogels for versatile protein drug delivery
Sandeep T. Koshy et al.
ACTA BIOMATERIALIA (2018)
Self-assembling toxin-based nanoparticles as self-delivered antitumoral drugs
Laura Sanchez-Garcia et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Release of targeted protein nanoparticles from functional bacterial amyloids: A death star-like approach
Ugutz Unzueta et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Challenges and Opportunities for the Subcutaneous Delivery of Therapeutic Proteins
Michael R. Turner et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Positive in vitro wound healing effects of functional inclusion bodies of a lipoxygenase from the Mexican axolotl
Anne Stamm et al.
MICROBIAL CELL FACTORIES (2018)
Protein-Based Therapeutic Killing for Cancer Therapies
Naroa Serna et al.
TRENDS IN BIOTECHNOLOGY (2018)
Conformational Conversion during Controlled Oligomerization into Nonamylogenic Protein Nanoparticles
Julieta M. Sanchez et al.
BIOMACROMOLECULES (2018)
Selective depletion of metastatic stem cells as therapy for human colorectal cancer
Maria Virtudes Cespedes et al.
EMBO MOLECULAR MEDICINE (2018)
Toward Understanding Drug Incorporation and Delivery from Biocompatible Metal-Organic Frameworks in View of Cutaneous Administration
Sara Rojas et al.
ACS OMEGA (2018)
Recent advances in porous nanoparticles for drug delivery in antitumoral applications: inorganic nanoparticles and nanoscale metal-organic frameworks
Alejandro Baeza et al.
EXPERT OPINION ON DRUG DELIVERY (2017)
Engineering tumor cell targeting in nanoscale amyloidal materials
Ugutz Unzueta et al.
NANOTECHNOLOGY (2017)
Metal-organic-frameworks for biomedical applications in drug delivery, and as MRI contrast agents
Mohammad A. Chowdhury
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2017)
Catalytically-active inclusion bodies Carrier-free protein immobilizates for application in biotechnology and biomedicine
Ulrich Krauss et al.
JOURNAL OF BIOTECHNOLOGY (2017)
Current status and perspectives of patient-derived xenograft models in cancer research
Yunxin Lai et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Bacterial Inclusion Bodies: Discovering Their Better Half
Ursula Rinas et al.
TRENDS IN BIOCHEMICAL SCIENCES (2017)
Mesoporous iron-carboxylate metal-organic frameworks synthesized by the double-template method as a nanocarrier platform for intratumoral drug delivery
Zhengfei Wu et al.
BIOMATERIALS SCIENCE (2017)
Chemokines and cocaine: CXCR4 receptor antagonist AMD3100 attenuates cocaine place preference and locomotor stimulation in rats
Jae Kim et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
Anti-cancer Drug Delivery Using Metal Organic Frameworks (MOFs)
Mihad Ibrahim et al.
CURRENT MEDICINAL CHEMISTRY (2017)
Functional protein-based nanomaterial produced in microorganisms recognized as safe: A new platform for biotechnology
Olivia Cano-Garrido et al.
ACTA BIOMATERIALIA (2016)
The application of halloysite tubule nanoclay in drug delivery
Yuri M. Lvov et al.
EXPERT OPINION ON DRUG DELIVERY (2016)
Antitumor effect of CXCR4 antagonist AMD3100 on the tumorigenic cell line of BHP10-3 papillary thyroid cancer cells
Young Ho Jung et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)
Functional inclusion bodies produced in the yeast Pichia pastoris
Fabian Rueda et al.
MICROBIAL CELL FACTORIES (2016)
Cellular uptake and intracellular fate of protein releasing bacterial amyloids in mammalian cells
Joaquin Seras-Franzoso et al.
SOFT MATTER (2016)
Designing hydrogels for controlled drug delivery
Jianyu Li et al.
NATURE REVIEWS MATERIALS (2016)
Amyloid formation of growth hormone in presence of zinc: Relevance to its storage in secretory granules
Reeba S. Jacob et al.
SCIENTIFIC REPORTS (2016)
Bacterial mimetics of endocrine secretory granules as immobilized in vivo depots for functional protein drugs
Maria Virtudes Cespedes et al.
SCIENTIFIC REPORTS (2016)
Maintaining Tumor Heterogeneity in Patient-Derived Tumor Xenografts
John W. Cassidy et al.
CANCER RESEARCH (2015)
Controlled Drug Delivery: Historical perspective for the next generation
Yeon Hee Yun et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Integrating mechanical and biological control of cell proliferation through bioinspired multieffector materials
Joaquin Seras-Franzoso et al.
NANOMEDICINE (2015)
Production of functional inclusion bodies in endotoxin-free Escherichia coli
Fabian Rueda et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2014)
Supramolecular organization of protein-releasing functional amyloids solved in bacterial inclusion bodies
Olivia Cano-Garrido et al.
ACTA BIOMATERIALIA (2013)
Unconventional microbial systems for the cost-efficient production of high-quality protein therapeutics
Jose Luis Corchero et al.
BIOTECHNOLOGY ADVANCES (2013)
Bacterial inclusion bodies as potential synthetic devices for pathogen recognition and a therapeutic substance release
Klaudia Talafova et al.
MICROBIAL CELL FACTORIES (2013)
Functional Inclusion Bodies Produced in Bacteria as Naturally Occurring Nanopills for Advanced Cell Therapies
Esther Vazquez et al.
ADVANCED MATERIALS (2012)
Inclusion bodies as potential vehicles for recombinant protein delivery into epithelial cells
Mirjana Liovic et al.
MICROBIAL CELL FACTORIES (2012)
Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review
Ketao Jin et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2010)
Inhibitory effect of CXC chemokine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis
Jeong Sup Song et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2010)
Isolation of cell-free bacterial inclusion bodies
Escarlata Rodriguez-Carmona et al.
MICROBIAL CELL FACTORIES (2010)
The CXCR4 Antagonist AMD3100 Has Dual Effects on Survival and Proliferation of Myeloma Cells In Vitro
Ha-Yon Kim et al.
CANCER RESEARCH AND TREATMENT (2010)
Surface Cell Growth Engineering Assisted by a Novel Bacterial Nanomaterial
Elena Garcia-Fruitos et al.
ADVANCED MATERIALS (2009)
Functional Amyloids As Natural Storage of Peptide Hormones in Pituitary Secretory Granules
Samir K. Maji et al.
SCIENCE (2009)
Bacterial inclusion bodies contain amyloid-like structure
Lei Wang et al.
PLOS BIOLOGY (2008)
Recombinant protein solubility - does more mean better?
Nuria Gonzalez-Montalban et al.
NATURE BIOTECHNOLOGY (2007)
Orthotopic microinjection of human colon cancer cells in nude mice induces tumor foci in all clinically relevant metastatic sites
Maria Virtudes Cespedes et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Ordered mesoporous materials in the context of drug delivery systems and bone tissue engineering
Maria Vallet-Regi
CHEMISTRY-A EUROPEAN JOURNAL (2006)
Contributions of human tumor xenografts to anticancer drug development
EA Sausville et al.
CANCER RESEARCH (2006)
Immunotoxins containing Pseudomonas exotoxin A:: a short history
I Pastan
CANCER IMMUNOLOGY IMMUNOTHERAPY (2003)
Share Paper
